ECPR for Refractory Out-Of-Hospital Cardiac Arrest

ClinicalTrials.gov ID: NCT03065647

Public ClinicalTrials.gov record NCT03065647. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Sep 6, 2026, 10:57 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Extracorporeal CPR for Refractory Out-of-Hospital Cardiac Arrest (EROCA)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

In the U.S. alone, over 300,000 people per year have sudden out-of-hospital cardiac arrest (OHCA), and less than 1 out of 10 survive. The current standard practice for treating OHCA is to perform cardiopulmonary resuscitation (CPR) and Advanced Cardiovascular Life Support (ACLS) at the scene until either the heart is restarted or resuscitation efforts are considered hopeless and discontinued. An alternative strategy for those with refractory OHCA is expedited transport with ongoing mechanical CPR to an Emergency Department capable of performing extracorporeal cardiopulmonary resuscitation (ECPR). The purpose of study is to test if this strategy is feasible and beneficial.

Study identification

NCT ID: NCT03065647
Recruitment status: Completed
Study type: Interventional
Phase: Not applicable
Lead sponsor: University of Michigan; Other
Enrollment: 15 participants

Conditions and interventions

Conditions

Interventions

Expedited Transport With Mechanical CPR Device

Device

Eligibility (public fields only)

Age range: 18 Years to 70 Years
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Apr 30, 2017
Primary completion: Mar 4, 2020
Completion: Mar 4, 2020
Last update posted: Jun 2, 2021

2017 – 2020

United States locations

U.S. sites: 1
U.S. states: 1
U.S. cities: 1

Facility	City	State	ZIP	Site status
University of Michigan Hospital	Ann Arbor	Michigan	48109	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT03065647, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Jun 2, 2021 · Synced Sep 6, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03065647 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →